Skip to main content

Table 1 Characteristics of study population

From: Variation in serum urate levels in the absence of gout and urate lowering therapy

Characteristic

Study population (n = 85)

Normouricemic at Screening (n = 72)

Hyperuricemic at Screening (n = 13)

Age at Enrollment (mean ± SD)

27.8 ± 7.0

27.9 ± 7.1

27.4 ± 7.3

Sex

 Male

52 (61%)

39 (54%)

13 (100%)

 Female

33 (39%)

33 (45%)

0 (0%)

Race/Ethnicity

 White

45 (53%)

37 (51%)

8 (62%)

 African-American

35 (41%)

32 (45%)

3 (23%)

 Other

5 (6%)

3 (4%)

2 (15%)

BMI (mean ± SD)

31.1 ± 7.9

30.8 ± 8.1

32.4 ± 6.6

Screening Serum urate (mean ± SD, mg/dL)

5.8 ± 1.2

  

 Men

6.4 ± 1.0

  

 Women

4.9 ± 0.7

  
  1. SD Standard deviation, mg/dL Milligrams per deciliter